Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol
Abstract Background The introduction of (m)FOLFIRINOX and gemcitabine-nab-paclitaxel has changed the perspective for patients with locally advanced pancreatic cancer (LAPC). Consequently, in experienced centres 23% of patients with LAPC undergo a resection with 5-year overall survival (OS) rates of...
Saved in:
Similar Items
-
Primary percutaneous stenting above the ampulla versus endoscopic drainage for unresectable malignant hilar biliary obstruction (TESLA RCT): study protocol for a multicenter randomized controlled trial
by: M. Rousian, et al.
Published: (2025-05-01) -
Comparison of Perinatal Outcome of Preterm Births Starting in Primary Care versus Secondary Care in Netherlands: A Retrospective Analysis of Nationwide Collected Data
by: A. J. van der Ven, et al.
Published: (2014-01-01) -
Decision Making about Localized Esophageal Cancer Treatment: An Observational Study on Variation in Clinicians’ Communication Behavior
by: L. F. van de Water, et al.
Published: (2025-06-01) -
A structured approach for data collection and visualization of the International Childhood Cancer Core Outcomes
by: R.J. van Kalsbeek, et al.
Published: (2025-06-01) -
The crisis of the third day in intracranial pressure dynamics following traumatic brain injury, fact or fiction?
by: R.D. Singh, et al.
Published: (2024-01-01)